Simple Summary In this review, we analyze the contribution of the most abundant immune
cell populations in hepatocellular carcinoma (HCC) progression and response to therapy …

Coronavirus disease 2019 (COVID-19) continuously affecting the lives of millions of people.
The virus is spread through the respiratory route to an uninfected person, causing mild-to …

The increasing incidence of hepatitis C virus (HCV) infections underscores the need for an
effective vaccine. Successful vaccines to other viruses generally depend on a long-lasting …

Background and Aims HCV‐specific T cells are few and exhausted in patients with chronic
hepatitis C (CHC). Whether these T cells are responsible for the liver damage and fibrosis is …

Factors affecting the probability of hepatocellular carcinoma (HCC) development even after
sustained virological response (SVR) following anti–hepatitis C virus (HCV) therapy remain …

The dysregulation of cytokine production can lead to an inefficient immune response,
promoting viral persistence that induces the progression of chronic viral hepatitis. The study …

From being described as “non-A, non-B” hepatitis in 1975 and being identified in 1989, to
the emergence of direct-acting antiviral drugs (DAAs), knowledge on hepatitis C virus (HCV) …

Background T cells are the primary effector cells that mediate viral clearance in spontaneous
recovery from HCV infection and T cell dysfunction is a hallmark of progression to chronic …

In chronic hepatitis B (CHB) and C (CHC) infections, the composition of the immune cell
microenvironment at the site of infection is poorly understood. Thus, our aim was to …

Le foie présente des capacités de tolérance particulières. Celles-ci peuvent être altérées et
conduire au développement de maladies auto-immunes hépatiques telles que l'hépatite …